ELIXF (Elixxer) Shiller PE Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Elixxer Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Elixxer  (OTCPK:ELIXF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Elixxer Shiller PE Ratio Related Terms


Elixxer Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Elixxer's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer Shiller PE Ratio Chart

Elixxer Annual Data
Trend Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Elixxer Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ELIXF vs ZTS: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Elixxer's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elixxer Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixxer's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Elixxer's Shiller PE Ratio falls into.



Elixxer Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Elixxer's E10 for the quarter that ended in Dec. 2025 is calculated as:

For example, Elixxer's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.123/130.3661*130.3661
=-0.123

Current CPI (Dec. 2025) = 130.3661.

Elixxer Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201509 -0.058 100.421 -0.075
201512 -0.093 99.947 -0.121
201603 -0.068 101.054 -0.088
201606 -0.546 102.002 -0.698
201609 0.000 101.765 0.000
201612 -0.165 101.449 -0.212
201703 -0.194 102.634 -0.246
201706 -0.143 103.029 -0.181
201709 -0.814 103.345 -1.027
201712 -1.566 103.345 -1.975
201803 -0.178 105.004 -0.221
201806 -2.286 105.557 -2.823
201809 0.000 105.636 0.000
201812 -0.363 105.399 -0.449
201903 -0.748 106.979 -0.912
201906 -0.753 107.690 -0.912
202003 -0.347 107.927 -0.419
202006 -0.119 108.401 -0.143
202009 0.034 108.164 0.041
202012 -0.546 108.559 -0.656
202103 0.247 110.298 0.292
202106 0.548 111.720 0.639
202109 -0.616 112.905 -0.711
202112 -0.086 113.774 -0.099
202203 -0.229 117.646 -0.254
202206 -0.555 120.806 -0.599
202209 0.003 120.648 0.003
202212 -0.213 120.964 -0.230
202303 -0.058 122.702 -0.062
202306 -0.068 124.203 -0.071
202309 -0.067 125.230 -0.070
202312 -0.067 125.072 -0.070
202403 -0.052 126.258 -0.054
202406 -0.036 127.522 -0.037
202409 -0.037 127.285 -0.038
202412 -0.098 127.364 -0.100
202503 -0.035 129.181 -0.035
202506 -0.037 129.892 -0.037
202509 -0.051 130.287 -0.051
202512 -0.123 130.366 -0.123

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Elixxer Business Description

Other Exchanges ELXR.H:Canada
Address 200 Bay Street, Suite 3240, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.